Lupin rises on getting USFDA’s approval for Rufinamide Tablets

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 688.15, up by 0.60 points or 0.09% from its previous closing of Rs. 687.55 on the BSE. The scrip opened at Rs. 685.00 and has touched a high and low of Rs. 691.80 and Rs. 678.85 respectively. So far 15453 shares were traded on the counter. The BSE group … Read more

Lupin rises on getting tentative approval for Ivacaftor Tablets from USFDA

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 612.10, up by 2.20 points or 0.36% from its previous closing of Rs. 609.90 on the BSE. The scrip opened at Rs. 607.00 and has touched a high and low of Rs. 614.60 and Rs. 603.00 respectively. So far 89358 shares were traded on the counter. The BSE group … Read more

Lupin moves up on the bourses

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 923.50, up by 20.05 points or 2.22% from its previous closing of Rs. 903.45 on the BSE. The scrip opened at Rs. 902.05 and has touched a high and low of Rs. 933.00 and Rs. 898.45 respectively. So far 150138 shares were traded on the counter. The BSE group … Read more

BREAKING NEWS:
Samsung Galaxy S25 series price cut by ₹30,000 in India! Airtel’s 30-Day Plans: Up to 60GB Data, Unlimited Calls! Samsung Galaxy S25 series gets ₹30,000 price cut in India!